Preferred Label : Cyclophosphamide/Docetaxel/Trastuzumab Regimen;
NCIt synonyms : Docetaxel/Cyclophosphamide Trastuzumab; Docetaxel Cyclophosphamide Trastuzumab; Docetaxel/Cyclophosphamide Plus Trastuzumab; Docetaxel-Cyclophosphamide-Trastuzumab Regimen; Docetaxel-Cyclophosphamide-Trastuzumab; Docetaxel/Cyclophosphamide/Trastuzumab Regimen;
NCIt related terms : TCH (Docetaxel, Cyclophosphamide); TC-H (Docetaxel) (trastuzumab-pkrb); TC-H (Docetaxel) (trastuzumab-herw); TCH (Docetaxel) (trastuzumab-pkrb); TCH (Docetaxel) (trastuzumab-anns); TCH (Docetaxel) (trastuzumab-dttb); TCH (Docetaxel) (trastuzumab-zerc); TC-H (Docetaxel) (trastuzumab-anns); TCH (Docetaxel) (trastuzumab-dkst); TC-H (Docetaxel); TCH (Docetaxel) (trastuzumab-qyyp); TC-H (Docetaxel) (trastuzumab-zerc); TC-H (Docetaxel) (trastuzumab-qyyp); TC-H (Docetaxel) (trastuzumab-dkst); TC-H (Docetaxel) (trastuzumab-dttb); TCH (Docetaxel) (trastuzumab-herw);
NCIt definition : A regimen consisting of docetaxel, cyclophosphamide and trastuzumab that can be used
in the treatment of breast cancer.;
NCIt note : Source: NCCN Guidelines 2017;
NCI Metathesaurus CUI : CL525011;
Codes from synonyms : 9488; 129446; 129349; 136305; 136304; 136307; 136306; 136309; 136308; 128961; 128864; 129252; 136310; 129155; 129058; 136311;
Origin ID : C138034;
UMLS CUI : C4527341;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
